Literature DB >> 24768159

Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism.

Elena A Kozina1, Gulnara R Khakimova1, Vitaly G Khaindrava2, Valeriayn G Kucheryanu3, Nadezhda E Vorobyeva4, Alexey N Krasnov4, Sophia G Georgieva4, Lidiya Kerkerian-Le Goff5, Michael V Ugrumov6.   

Abstract

Progressive degeneration of nigrostriatal dopaminergic (DA-ergic) neurons is a key component in the pathogenesis of Parkinson's disease, which develops for a long time at the preclinical stage with no motor dysfunctions due to the initiation of compensatory processes. The goal of this study was to evaluate the changes in surviving nigrostriatal DA-ergic neurons with focus on tyrosine hydroxylase (TH) in MPTP-treated mice at the presymptomatic and early symptomatic stages of parkinsonism. According to our data, a partial degeneration of DA-ergic neurons at the presymptomatic stage was accompanied by: (i) no change in TH mRNA content in the substantia nigra (SN) suggesting a compensatory increase of TH gene expression in individual neurons; (ii) a decrease of TH protein content in the nigrostriatal system and no change in individual neurons, suggesting a slowdown of TH translation. When comparing DA-ergic neurons at the early symptomatic stage and presymptomatic stage, it becomes evident: (i) a decrease of TH mRNA content in the SN and hence gene expression in individual neurons; (ii) a decrease of TH content in the striatum and its increase in the SN and individual neurons suggesting an acceleration of TH translation. TH activity, an index of the rate of DA synthesis, was unchanged in the SN and decreased in the striatum to the same degree at both stages of parkinsonism. In the meantime, TH activity in individual neurons appeared to be compensatory increased, but to a higher degree at the symptomatic stage than at the presymptomatic one. These data first show that DA depletion, which provokes motor dysfunction, is not a result of the decrease of TH activity and the rate of DA synthesis but is rather related to either a decrease of DA release or an increase of DA uptake in striatal DA-ergic axons.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Dopamine; Mice; Nigrostriatal system; Parkinson's disease; Tyrosine hydroxylase

Mesh:

Substances:

Year:  2014        PMID: 24768159     DOI: 10.1016/j.jns.2014.03.028

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  17 in total

1.  Molecular mechanisms of synthesis of noradrenaline as an inducer of development in the adrenal glands of rats in ontogenesis.

Authors:  N S Bondarenko; A R Murtazina; Yu O Nikishina; A Ya Sapronova; M V Ugrumov
Journal:  Dokl Biochem Biophys       Date:  2017-04-19       Impact factor: 0.788

2.  Gene expression of proteins of the vesicle cycle in the striatum and motor cortex under functional failure of nigrostriatal system.

Authors:  E R Mingazov; M V Ugrumov
Journal:  Dokl Biochem Biophys       Date:  2016-11-06       Impact factor: 0.788

3.  Gene expression of proteins of the vesicle cycle in dopaminergic neurons in modeling of Parkinson's disease.

Authors:  E R Mingazov; M V Ugrumov
Journal:  Dokl Biochem Biophys       Date:  2016-07-15       Impact factor: 0.788

4.  Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss.

Authors:  Gelareh Alam; Melissa Edler; Shelbie Burchfield; Jason R Richardson
Journal:  Neurotoxicology       Date:  2017-04-01       Impact factor: 4.294

Review 5.  Proteasome-mediated degradation of tyrosine hydroxylase triggered by its phosphorylation: a new question as to the intracellular location at which the degradation occurs.

Authors:  Akira Nakashima; Yu Kodani; Yoko S Kaneko; Hiroshi Nagasaki; Akira Ota
Journal:  J Neural Transm (Vienna)       Date:  2016-11-19       Impact factor: 3.575

6.  MPTP Mouse Model of Preclinical and Clinical Parkinson's Disease as an Instrument for Translational Medicine.

Authors:  Eduard R Mingazov; Gulnara R Khakimova; Elena A Kozina; Alexei E Medvedev; Olga A Buneeva; Ara S Bazyan; Michael V Ugrumov
Journal:  Mol Neurobiol       Date:  2017-04-29       Impact factor: 5.590

7.  Transcriptome Profile Changes in Mice with MPTP-Induced Early Stages of Parkinson's Disease.

Authors:  Anelya Kh Alieva; Elena V Filatova; Anna A Kolacheva; Margarita M Rudenok; Petr A Slominsky; Mikhail V Ugrumov; Maria I Shadrina
Journal:  Mol Neurobiol       Date:  2016-10-18       Impact factor: 5.590

8.  Effects of Agmatine on Depressive-Like Behavior Induced by Intracerebroventricular Administration of 1-Methyl-4-phenylpyridinium (MPP(+)).

Authors:  Morgana Moretti; Vivian Binder Neis; Filipe Carvalho Matheus; Mauricio Peña Cunha; Priscila Batista Rosa; Camille Mertins Ribeiro; Ana Lúcia S Rodrigues; Rui Daniel Prediger
Journal:  Neurotox Res       Date:  2015-07-09       Impact factor: 3.911

9.  Hesperidin protects against behavioral alterations and loss of dopaminergic neurons in 6-OHDA-lesioned mice: the role of mitochondrial dysfunction and apoptosis.

Authors:  Michelle S Antunes; Fernando Vagner Lobo Ladd; Aliny Antunes Barbosa Lobo Ladd; Amanda Lopez Moreira; Silvana Peterini Boeira; Leandro Cattelan Souza
Journal:  Metab Brain Dis       Date:  2020-10-15       Impact factor: 3.584

10.  Psychological Stress Phenocopies Brain Mitochondrial Dysfunction and Motor Deficits as Observed in a Parkinsonian Rat Model.

Authors:  Mariana Grigoruţă; Alejandro Martínez-Martínez; Raul Y Dagda; Ruben K Dagda
Journal:  Mol Neurobiol       Date:  2019-12-14       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.